-
Bio-Techne’s Ella Platform Secures CE-IVD Mark, Revolutionizing European Immunoassay Testing
NASDAQ: $TECH Bio-Techne Corporation, a leading global supplier of life science tools, reagents, and diagnostic products, has announced a major milestone: the Ella benchtop immunoassay platform has officially achieved CE-IVD marking and is now available for purchase throughout the European Union. This crucial certification opens the door for European clinical laboratories to adopt Ella’s industry-leading…
-
Azenta Life Sciences and Frontier Space Forge Alliance to Advance Research Infrastructure Beyond Earth
NASDAQ: $AZTA A New Frontier for Life Sciences: Azenta Partners with Frontier Space for Space-Based Research Azenta, Inc., a global leader in life sciences solutions, has announced a significant strategic partnership with Frontier Space, a pioneer in commercial space-based research systems. This collaboration marks a pivotal moment, uniting Azenta’s expertise in sample management with Frontier…
-
Atossa Therapeutics Reinforces Z-Endoxifen’s Value Following Priority Review Voucher Program Reauthorization
NASDAQ: $ATOS Atossa Therapeutics, Inc. has underscored the continued strategic significance of its lead drug candidate, Z-Endoxifen, for the treatment of Duchenne Muscular Dystrophy (DMD). This reinforcement comes directly on the heels of recent legislative action by the U.S. Congress to reauthorize the Priority Review Voucher (PRV) program. Z-Endoxifen and the Importance of the PRV…
-
SBC Medical Supported Nasukai and Daibi Medical Aesthetics Forge Strategic Alliance to Enhance Patient Care
NASDAQ: $SBC SBC Medical Supported Medical Corporation Nasukai, a prominent entity in the medical sector, today announced the formation of a significant strategic alliance with Daibi Medical Aesthetics. This collaboration marks a pivotal moment for both organizations, signaling a commitment to expanding high-quality medical services and enhancing patient experience across their respective domains. SBC is…
-
SweetWater Brewing Announces ‘Big Trip’ Double IPA: A Bold New Flavor for Craft Beer Enthusiasts
NASDAQ: $TLRY Craft beer aficionados, get ready to mark your calendars! SweetWater Brewing Company, known for its distinctive style and commitment to quality brewing, has just announced the arrival of a highly anticipated new addition to its lineup: the Big Trip Double IPA. This news, officially released via a press statement on January 22, 2026,…
-
PDS Biotech Secures New U.S. Patent for Core Technology
NASDAQ: $PDSB Pharmaceutical development is a meticulous and often lengthy process, where intellectual property protection is paramount to innovation. In a significant move for the sector, PDS Biotech recently announced the issuance of a new U.S. Patent. This patent specifically covers the fundamental technology platform that underpins one of the company’s key investigational products, PDS0.…
-
A Significant Advance in RRP Treatment: Papizimeos Reaches New Standard of Care Status
NASDAQ: $PGEN A landmark development in the treatment of Recurrent Respiratory Papillomatosis (RRP) has recently been announced, marking a potential shift in clinical practice for thousands of patients worldwide. A new expert consensus, formally published in the prestigious medical journal, The Laryngoscope, strongly recommends Papizimeos (zopapogene imadenovec) as the new standard of care for first-line…
-
RenovoRx’s RenovoCath System Gains Traction: Expanding to Nine Leading Cancer Centers
NASDAQ: $RNXT The landscape of localized cancer treatment is witnessing significant evolution, and RenovoRx, Inc. is at the forefront of this shift. A recent announcement highlights a major milestone for the company: the expansion of the commercial adoption of its innovative RenovoCath® system across nine active cancer centers in the United States. This expansion signifies…